PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsButylscopolamine bromide
Butylscopolamine bromide
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
558 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.91541897145257
Lung diseasesD008171EFO_0003818J98.4829683925167
Obstructive lung diseasesD008173621453522126
AsthmaD001249EFO_0000270J452141612851
Healthy volunteers/patients2211327
Respiratory aspirationD053120EFO_10018394282117
NauseaD009325R11.014813
VomitingD014839R11.114712
Postoperative nausea and vomitingD020250EFO_0004888112610
PainD010146EFO_0003843R5211439
Show 72 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Motion sicknessD009041T75.324913
Altitude sicknessD000532EFO_1000782T70.293114
InflammationD007249MP_00018452113
Disease progressionD018450112
DysmenorrheaD004412N94.6112
SmokingD012907EFO_00043181112
Cardiovascular diseasesD002318EFO_0000319I98112
Critical illnessD0166381112
Premature birthD047928EFO_0003917O601112
Colorectal neoplasmsD015179112
Show 17 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Depressive disorderD003866EFO_1002014F32.A2215
Olfaction disordersD000857R43.033
AnosmiaD000086582123
Bipolar disorderD001714EFO_0000289F30.933
LeukemiaD007938C9522
Gastrointestinal diseasesD005767112
Digestive system diseasesD004066EFO_0000405K92.9112
Acute painD059787R52112
Covid-19D000086382U07.122
Ovarian neoplasmsD010051EFO_0003893C561112
Show 29 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cognitive dysfunctionD060825G31.84415
Alzheimer diseaseD000544EFO_0000249F0344
Memory disordersD008569213
DementiaD003704EFO_0003862F0333
PharmacokineticsD01059922
Prostatic neoplasmsD011471C61112
HypertensionD006973EFO_0000537I1022
Pulmonary hypertensionD006976EFO_0001361I27.2022
Breast neoplasmsD001943EFO_0003869C50112
Organophosphate poisoningD062025112
Show 17 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
RhytidoplastyD01536111
DeliriumD003693R41.011
Systemic sclerodermaD012595EFO_0000717M3411
Diffuse sclerodermaD045743EFO_000040411
SclerosisD01259811
ObesityD009765EFO_0001073E66.911
Headache disordersD020773EFO_0009550G4411
Central nervous system diseasesD002493G96.911
Nervous system diseasesD009422G00-G9911
Ganglion cystsD045888M67.411
Show 32 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
1,177 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use